NO953832L - Sykliske forbindelser som kan anvendes som inhibitorer for blodplateglykoprotein IIb/IIIa - Google Patents
Sykliske forbindelser som kan anvendes som inhibitorer for blodplateglykoprotein IIb/IIIaInfo
- Publication number
- NO953832L NO953832L NO953832A NO953832A NO953832L NO 953832 L NO953832 L NO 953832L NO 953832 A NO953832 A NO 953832A NO 953832 A NO953832 A NO 953832A NO 953832 L NO953832 L NO 953832L
- Authority
- NO
- Norway
- Prior art keywords
- cyclic compounds
- platelet
- glycoprotein iib
- iiia
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3844893A | 1993-03-29 | 1993-03-29 | |
| PCT/US1994/003223 WO1994022910A1 (en) | 1993-03-29 | 1994-03-28 | CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO953832D0 NO953832D0 (no) | 1995-09-28 |
| NO953832L true NO953832L (no) | 1995-11-28 |
Family
ID=21900014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953832A NO953832L (no) | 1993-03-29 | 1995-09-28 | Sykliske forbindelser som kan anvendes som inhibitorer for blodplateglykoprotein IIb/IIIa |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0691987A1 (fi) |
| JP (1) | JPH08508498A (fi) |
| AU (1) | AU6415894A (fi) |
| CA (1) | CA2159070A1 (fi) |
| FI (1) | FI954556A (fi) |
| HU (1) | HUT72896A (fi) |
| NO (1) | NO953832L (fi) |
| NZ (1) | NZ263456A (fi) |
| PL (1) | PL310896A1 (fi) |
| WO (1) | WO1994022910A1 (fi) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2159072A1 (en) * | 1993-03-29 | 1994-10-13 | Lin-Hua Zhang | Novel processes and intermediate compounds for the preparation of platelet glycoprotein iib/iiia inhibitors |
| US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| CA2272317C (en) * | 1996-11-27 | 2001-01-30 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound |
| US6010911A (en) * | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
| US6537520B1 (en) | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
| GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
| JP5649825B2 (ja) | 2007-01-31 | 2015-01-07 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 安定化させたｐ５３ペプチドおよびその使用法 |
| CA2682174C (en) | 2007-03-28 | 2021-04-06 | President And Fellows Of Harvard College | Stitched polypeptides |
| US11673914B2 (en) | 2009-11-10 | 2023-06-13 | Allegro Pharmaceuticals, LLC | Peptide therapies for reduction of macular thickening |
| BR112012011731A2 (pt) * | 2009-11-10 | 2020-08-25 | Allegro Pharmaceuticals, Inc. | composições e métodos para inibir a adesão celular ou direcionamento dos agentes de diagnóstico ou terapêuticos para os sítios de ligação rgd |
| PL2603600T3 (pl) | 2010-08-13 | 2019-06-28 | Aileron Therapeutics, Inc. | Makrocykle peptidomometyczne |
| JP6106159B2 (ja) | 2011-05-09 | 2017-03-29 | アレグロ ファーマシューティカルズ インコーポレイテッドＡｌｌｅｇｒｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | Ｒ−ｇ−システイン酸ペプチドを含む医薬組成物 |
| AR088392A1 (es) | 2011-10-18 | 2014-05-28 | Aileron Therapeutics Inc | Macrociclos peptidomimeticos |
| CN104144695A (zh) | 2012-02-15 | 2014-11-12 | 爱勒让治疗公司 | 三唑交联的和硫醚交联的拟肽大环化合物 |
| RU2017145921A (ru) | 2012-02-15 | 2019-02-21 | Эйлерон Терапьютикс, Инк. | Пептидомиметические макроциклы |
| KR20150082307A (ko) | 2012-11-01 | 2015-07-15 | 에일러론 테라퓨틱스 인코포레이티드 | 이치환 아미노산 및 이의 제조 및 사용 방법 |
| SG11201702175YA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and formulations thereof |
| SG10201902594QA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
| KR20170129879A (ko) | 2015-03-20 | 2017-11-27 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방 거대고리 및 이의 용도 |
| CN108368161A (zh) | 2015-09-10 | 2018-08-03 | 艾瑞朗医疗公司 | 作为mcl-1调节剂的拟肽大环化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2636066B1 (fr) * | 1988-09-02 | 1991-10-25 | Centre Nat Rech Scient | Derives de cyclopeptides, utilisables comme inhibiteurs selectifs vis-a-vis de proteases a serine active |
| US5384309A (en) * | 1989-07-17 | 1995-01-24 | Genentech, Inc. | Cyclized peptides and their use as platelet aggregation inhibitors |
| AU6470590A (en) * | 1989-10-23 | 1991-04-26 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
| IL103252A (en) * | 1991-09-30 | 1997-03-18 | Du Pont Merck Pharma | CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1994
- 1994-03-28 PL PL94310896A patent/PL310896A1/xx unknown
- 1994-03-28 CA CA002159070A patent/CA2159070A1/en not_active Abandoned
- 1994-03-28 EP EP94911703A patent/EP0691987A1/en not_active Withdrawn
- 1994-03-28 NZ NZ263456A patent/NZ263456A/en not_active IP Right Cessation
- 1994-03-28 WO PCT/US1994/003223 patent/WO1994022910A1/en not_active Application Discontinuation
- 1994-03-28 HU HU9502832A patent/HUT72896A/hu unknown
- 1994-03-28 AU AU64158/94A patent/AU6415894A/en not_active Abandoned
- 1994-03-28 JP JP6522195A patent/JPH08508498A/ja not_active Ceased
-
1995
- 1995-09-26 FI FI954556A patent/FI954556A/fi unknown
- 1995-09-28 NO NO953832A patent/NO953832L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI954556A0 (fi) | 1995-09-26 |
| FI954556A (fi) | 1995-09-26 |
| NZ263456A (en) | 1996-11-26 |
| EP0691987A1 (en) | 1996-01-17 |
| AU6415894A (en) | 1994-10-24 |
| WO1994022910A1 (en) | 1994-10-13 |
| JPH08508498A (ja) | 1996-09-10 |
| PL310896A1 (en) | 1996-01-08 |
| NO953832D0 (no) | 1995-09-28 |
| HU9502832D0 (en) | 1995-11-28 |
| CA2159070A1 (en) | 1994-10-13 |
| HUT72896A (en) | 1996-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953832L (no) | Sykliske forbindelser som kan anvendes som inhibitorer for blodplateglykoprotein IIb/IIIa | |
| DK36991A (da) | Vaevsplasminoaktivator-(t-pa)-variant med zymogene eller fibrinspecifikke eller plasmakoagel-specifikke egenskaber, fremgangsmaade til fremstilling deraf, dna-sekvens, som koder for varianten, replicerbar udtrykkelsesvektor for denne og vaertsceller transformeret med vektoren | |
| Siigur et al. | Biochemical characterization of lebetase, a direct-acting fibrinolytic enzyme from Vipera lebetina snake venom | |
| DK0730590T3 (da) | Isoxazolin og isozazol fibrinogenreceptorantagonister | |
| Marshall et al. | Coagulant and anticoagulant actions of Australian snake venoms | |
| Suntravat et al. | cDNA cloning of a snake venom metalloproteinase from the eastern diamondback rattlesnake (Crotalus adamanteus), and the expression of its disintegrin domain with anti-platelet effects | |
| Korhonen | Fibrinolytic and procoagulant activities of Yersinia pestis and Salmonella enterica | |
| ES2120713T3 (es) | Compuestos de isoxazolinas utiles como antagonistas de receptores del fibrinogeno. | |
| Collen | Thrombolytic therapy | |
| DE59409104D1 (de) | Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung | |
| ES2337879T3 (es) | Procedimiento de dosificacion de la fibrina soluble. | |
| Chu et al. | Purification and characterization of a novel fibrinolytic enzyme from Whitmania pigra Whitman | |
| Bisacchi | Anticoagulants, antithrombotics, and hemostatics | |
| Moukhametova et al. | Properties of the urokinase-type plasminogen activator modified with phenylglyoxal | |
| Bachmann | Fibrinolytic agents | |
| Matsushima et al. | Activation of fibrinolysis with the protease from Dermatophagoides farinae | |
| Lucena et al. | Degradation of extracellular matrix proteins (fibronectin, vitronectin and laminin) by serine-proteinases isolated from Lonomia achelous caterpillar hemolymph | |
| Devi et al. | Coagulant and esterase activities of thrombin and Bothrops atrox venom | |
| South et al. | Conformational quiescence of ADAMTS‐13 prevents proteolytic promiscuity: reply | |
| Guerrero et al. | Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model | |
| Suehiro et al. | Enhancing effect of platelets on staphylokinase-mediated clot lysis and plasminogen activation | |
| Islam et al. | Longistatin, a novel plasminogen activator from vector ticks, is resistant to plasminogen activator inhibitor-1 | |
| Budnik et al. | Effects of tranexamic acid, factor XIII, and fibrinogen on clot formation and lysis in the model of hyperfibrinolysis induced by tissue-vs urokinase-type plasminogen activator | |
| MacGillivray et al. | Structure of the genes encoding proteins involved in blood clotting | |
| Men'shikov | Influence of fibrinolysis system on ADP-and serotonin-induced aggregation of human platelets |